Skip to main content

Immunovant, Inc.

IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001764013

In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Immunovant, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
10 filings
6 insiders, $1.12M in total
Insiders trading
6
Net value
−$1.12M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Immunovant, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Immunovant, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Van Tuyl ChristopherChief Legal Officer176,545Sep 25, 20268
Pande AtulDirector116,731Aug 28, 20266
Gloria MelanieChief Operating Officer219,301Aug 21, 20268
Girao TiagoChief Financial Officer240,798Jul 24, 20264
Stout Jay SChief Technology Officer205,341Jul 24, 202610
Venker EricChief Executive Officer254,280Jul 6, 20263
Fromkin Andrew J.Director74,382May 29, 20263
Susman Robert GrahamDirector36,394May 1, 20262
Torti FrankDirector1,009,228Apr 9, 20261
Bauer JakeDirector38,896Apr 9, 20261
Hughes Douglas J.Director134,653Apr 9, 20262
Roivant Sciences Ltd.Director, 10% Owner113,317,007Dec 12, 20251
Geffner MichaelChief Medical Officer217,958Oct 24, 20252
Salzmann PeterChief Executive Officer1,178,191Apr 17, 20250
Barnett Eva ReneeChief Financial Officer396,774Apr 17, 20250
Migausky George VDirector137,251Apr 3, 20250
Macias William L.Chief Medical Officer357,353Feb 21, 20250
Levine Mark S.Chief Legal Officer319,228Nov 22, 20240
Butchko Julia G.Chief Development Officer440,959Aug 23, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 25, 2026 (view filing)4:05 PM ETSep 232 daysVan Tuyl ChristopherChief Legal OfficerSSale−2.85K$36.36−$103.5K−1.6%176.5K after
Aug 28, 2026 (view filing)4:27 PM ETAug 28Same dayPande AtulDirectorSSale−1.50K$43.27−$64.9K−1.3%116.7K after10b5-1
Aug 21, 2026 (view filing)4:03 PM ETAug 201 dayGloria MelanieChief Operating OfficerSSale−3.06K$44.16−$135.0K−1.4%219.3K after
Jul 24, 2026 (view filing)5:59 PM ETJul 24Same dayPande AtulDirectorSSale−1.50K$39.80−$59.7K−1.3%116.7K after10b5-1
Jul 24, 2026 (view filing)5:57 PM ETJul 231 dayGirao TiagoChief Financial OfficerSSale−6.80K$38.69−$263.0K−2.7%240.8K after
Jul 24, 2026 (view filing)5:57 PM ETJul 231 dayStout Jay SChief Technology OfficerSSale−2.86K$38.69−$110.5K−1.4%205.3K after
Jul 10, 2026 (view filing)4:15 PM ETJul 82 daysGloria MelanieChief Operating OfficerSSale−2.04K$39.55−$80.5K−0.9%222.4K after2 lots
Jul 10, 2026 (view filing)4:13 PM ETJul 82 daysVan Tuyl ChristopherChief Legal OfficerSSale−1.21K$39.55−$47.7K−0.7%179.4K after2 lots
Jul 10, 2026 (view filing)4:12 PM ETJul 82 daysStout Jay SChief Technology OfficerSSale−3.49K$39.55−$137.9K−1.6%208.2K after4 lots
Jul 6, 2026 (view filing)5:01 PM ETJul 24 daysVenker EricChief Executive OfficerSSale−3.09K$38.48−$119.0K−1.2%254.3K after
Jun 26, 2026 (view filing)Jun 26Same dayGloria MelanieChief Operating OfficerSSale−17.7K$38.31−$678.6K−7.3%224.4K after2 lots
Jun 26, 2026 (view filing)Jun 26Same dayStout Jay SChief Technology OfficerSSale−40.0K$38.31−$1.53M−15.9%211.7K after2 lots
Jun 26, 2026 (view filing)Jun 26Same dayVan Tuyl ChristopherChief Legal OfficerSSale−17.8K$38.31−$682.9K−9.0%180.6K after2 lots
Jun 26, 2026 (view filing)Jun 26Same dayGirao TiagoChief Financial OfficerSSale−10.0K$38.46−$384.6K−3.9%247.6K after
Jun 26, 2026 (view filing)Jun 26Same dayPande AtulDirectorSSale−1.50K$38.01−$57.0K−1.3%116.7K after10b5-1
Jun 22, 2026 (view filing)Jun 184 daysVan Tuyl ChristopherChief Legal OfficerSSale−2.63K$35.39−$93.2K−1.4%180.6K after
Jun 16, 2026 (view filing)Jun 151 dayPande AtulDirectorSSale−1.50K$34.02−$51.0K−1.3%116.7K after10b5-1
May 29, 2026 (view filing)May 281 dayFromkin Andrew J.DirectorSSale−222.0K$33.51−$7.44M−74.9%74.4K after2 lots
May 22, 2026 (view filing)May 202 daysGloria MelanieChief Operating OfficerSSale−3.12K$32.45−$101.1K−1.3%242.1K after3 lots
May 20, 2026 (view filing)May 20Same dayPande AtulDirectorSSale−6.00K$32.00−$192.0K−4.9%116.7K after10b5-1
May 1, 2026 (view filing)May 1Same daySusman Robert GrahamDirectorSSale−2.50K$27.17−$68.0K−6.4%36.4K after10b5-1
Apr 24, 2026 (view filing)Apr 231 dayGirao TiagoChief Financial OfficerSSale−25.8K$29.62−$763.0K−9.4%247.6K after
Apr 24, 2026 (view filing)Apr 231 dayStout Jay SChief Technology OfficerSSale−2.75K$29.62−$81.6K−1.1%251.7K after
Apr 10, 2026 (view filing)Apr 82 daysGloria MelanieChief Operating OfficerSSale−8.72K$24.83−$216.6K−3.4%245.2K after
Apr 10, 2026 (view filing)Apr 82 daysVan Tuyl ChristopherChief Legal OfficerSSale−5.17K$24.83−$128.2K−2.7%183.2K after
Apr 10, 2026 (view filing)Apr 82 daysStout Jay SChief Technology OfficerSSale−10.1K$24.83−$251.6K−3.8%254.4K after2 lots
Apr 3, 2026 (view filing)Apr 21 dayVenker EricChief Executive OfficerSSale−14.2K$24.10−$342.9K−42.1%19.6K after2 lots
Mar 20, 2026 (view filing)Mar 182 daysVan Tuyl ChristopherChief Legal OfficerSSale−2.88K$24.97−$71.8K−1.9%147.1K after
Feb 27, 2026 (view filing)Feb 252 daysGloria MelanieChief Operating OfficerSSale−3.24K$27.85−$90.2K−1.9%170.3K after3 lots
Jan 23, 2026 (view filing)Jan 212 daysStout Jay SChief Technology OfficerSSale−1.98K$26.03−$51.5K−1.0%197.6K after
Jan 9, 2026 (view filing)Jan 72 daysStout Jay SChief Technology OfficerSSale−1.20K$26.53−$31.9K−0.6%199.6K after2 lots
Dec 19, 2025 (view filing)Dec 181 dayVan Tuyl ChristopherChief Legal OfficerSSale−10.8K$26.91−$290.9K−6.7%149.9K after2 lots
Dec 12, 2025 (view filing)Dec 12Same dayRoivant Sciences Ltd.Director, 10% OwnerPPurchaseCommon Stock, $0.0001 par value per share+16.7M$21.00+$350.0M+17.2%113.3M after
Dec 3, 2025 (view filing)Dec 12 daysFromkin Andrew J.DirectorSSale−22.2K$23.25−$517.2K−20.6%85.9K after2 lots10b5-1
Dec 3, 2025 (view filing)Dec 12 daysHughes Douglas J.DirectorSSale−15.0K$23.24−$348.7K−11.0%120.8K after2 lots10b5-1
Nov 21, 2025 (view filing)Nov 201 dayGloria MelanieChief Operating OfficerSSale−12.6K$23.62−$298.2K−6.8%173.5K after2 lots
Oct 24, 2025 (view filing)Oct 222 daysGeffner MichaelChief Medical OfficerSSale−2.60K$19.03−$49.4K−1.2%218.0K after
Oct 24, 2025 (view filing)Oct 222 daysStout Jay SChief Technology OfficerSSale−2.52K$19.03−$48.0K−1.2%200.8K after
Oct 10, 2025 (view filing)Oct 82 daysGeffner MichaelChief Medical OfficerSSale−1.27K$16.30−$20.7K−0.6%220.6K after
Oct 10, 2025 (view filing)Oct 82 daysStout Jay SChief Technology OfficerSSale−1.58K$16.30−$25.8K−0.8%203.3K after
Jul 25, 2025 (view filing)Jul 232 daysStout Jay SChief Technology OfficerSSale−2.81K$18.15−$50.9K−1.4%204.9K after
Jul 25, 2025 (view filing)Jul 232 daysGeffner MichaelChief Medical OfficerSSale−2.38K$18.15−$43.3K−1.1%221.8K after
Jul 11, 2025 (view filing)Jul 92 daysGeffner MichaelChief Medical OfficerSSale−1.16K$17.24−$20.0K−0.5%224.2K after
Jul 11, 2025 (view filing)Jul 92 daysStout Jay SChief Technology OfficerSSale−1.52K$17.24−$26.2K−0.7%207.7K after
Apr 25, 2025 (view filing)Apr 232 daysStout Jay SChief Technology OfficerSSale−1.93K$14.79−$28.5K−0.9%209.2K after
Apr 25, 2025 (view filing)Apr 232 daysGeffner MichaelChief Medical OfficerSSale−2.35K$14.79−$34.7K−1.0%225.4K after
Apr 17, 2025 (view filing)Apr 161 dayBarnett Eva ReneeChief Financial OfficerSSale−2.99K$14.89−$44.6K−0.7%396.8K after
Apr 17, 2025 (view filing)Apr 161 daySalzmann PeterChief Executive OfficerSSale−8.32K$14.89−$123.9K−0.7%1.18M after
Apr 11, 2025 (view filing)Apr 92 daysStout Jay SChief Technology OfficerSSale−5.00K$12.99−$65.0K−2.3%211.2K after
Apr 11, 2025 (view filing)Apr 92 daysGeffner MichaelChief Medical OfficerSSale−6.17K$12.99−$80.1K−2.6%227.7K after